Malignant gliomas induce HLA-E or Lectin-like transcript-1 (LLT1), which can induce NK cell inhibition by binding CD94/NKG2A and CD161, respectively (51, 84–86) (Figure 1C). The gene discussed is CLEC2D; the disease is malignant glioma.